Pharmacokinetics of nitroglycerin and its metabolites after administration of sustained-release tablets.

PubWeight™: 0.77‹?›

🔗 View Article (PMID 1550909)

Published in Biopharm Drug Dispos on March 01, 1992

Authors

H R Kwon1, P Green, S H Curry

Author Affiliations

1: College of Pharmacy, University of Florida, Gainesville 32610.

Articles citing this

Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate. Br J Pharmacol (1993) 0.75

Articles by these authors

(truncated to the top 100)

Base-calling of automated sequencer traces using phred. II. Error probabilities. Genome Res (1998) 106.16

Base-calling of automated sequencer traces using phred. I. Accuracy assessment. Genome Res (1998) 96.63

Consed: a graphical tool for sequence finishing. Genome Res (1998) 59.36

MAPMAKER: an interactive computer package for constructing primary genetic linkage maps of experimental and natural populations. Genomics (1987) 54.39

Construction of multilocus genetic linkage maps in humans. Proc Natl Acad Sci U S A (1987) 35.83

Global water resources: vulnerability from climate change and population growth. Science (2000) 16.61

A genetic linkage map of the human genome. Cell (1987) 13.37

Comparative analyses of multi-species sequences from targeted genomic regions. Nature (2003) 13.31

Global threats to human water security and river biodiversity. Nature (2010) 11.84

Automated finishing with autofinish. Genome Res (2001) 7.97

Genes galore: a summary of methods for accessing results from large-scale partial sequencing of anonymous Arabidopsis cDNA clones. Plant Physiol (1994) 7.42

Analysis of expressed sequence tags indicates 35,000 human genes. Nat Genet (2000) 6.11

The C. elegans genome sequencing project: a beginning. Nature (1992) 5.36

OSP: a computer program for choosing PCR and DNA sequencing primers. PCR Methods Appl (1991) 4.72

A survey of expressed genes in Caenorhabditis elegans. Nat Genet (1992) 4.63

Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs. J Gen Microbiol (1983) 4.52

Identification of p53 gene mutations in bladder cancers and urine samples. Science (1991) 3.68

Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome 1p. N Engl J Med (1989) 3.03

Genetic linkage map of human chromosome 7 with 63 DNA markers. Proc Natl Acad Sci U S A (1987) 2.91

Detecting patterns in protein sequences. J Mol Biol (1994) 2.16

World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for evaluating the efficacy of parasiticides for the treatment, prevention and control of flea and tick infestation on dogs and cats. Vet Parasitol (2006) 2.09

Multipoint linkage analysis in neurofibromatosis type I: an international collaboration. Am J Hum Genet (1989) 2.04

Interaction of cAMP receptor protein with the ompA gene, a gene for a major outer membrane protein of Escherichia coli. FEBS Lett (1981) 1.94

Oligonucleotide probe for detection and identification of Campylobacter pylori. J Clin Microbiol (1989) 1.90

Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats. Eur J Neurosci (2004) 1.89

Idiopathic mouth ulcers in sheep, cattle and horses. Vet Rec (2001) 1.80

Determination of nanogram quantities of chlorpromazine and some of its metabolites in plasma using gas-liquid chromatography with an electron capture detector. Anal Chem (1968) 1.80

The novel endocannabinoid receptor GPR55 is activated by atypical cannabinoids but does not mediate their vasodilator effects. Br J Pharmacol (2007) 1.74

Sequence-tagged site (STS) content mapping of human chromosomes: theoretical considerations and early experiences. PCR Methods Appl (1991) 1.70

Identification of candidate coding region single nucleotide polymorphisms in 165 human genes using assembled expressed sequence tags. Genome Res (1999) 1.70

Scan of human genome reveals no new Loci under ancient balancing selection. Genetics (2006) 1.68

Thermosensitive H1 plasmids determining citrate utilization. J Gen Microbiol (1978) 1.62

Electrophysiological indicator of awakening from coma. Lancet (1993) 1.61

Control of early neurogenesis of the Drosophila brain by the head gap genes tll, otd, ems, and btd. Dev Biol (1997) 1.57

Clinical and biochemical comparison of clorazepate and diazepam. Psychol Med (1974) 1.46

AIDS-related cholangiopancreatographic changes. Abdom Imaging (1994) 1.46

Influence of posture on plasma nitroglycerin. Br J Clin Pharmacol (1985) 1.45

Amnioinfusion in very early preterm prelabor rupture of membranes (AMIPROM): pregnancy, neonatal and maternal outcomes in a randomized controlled pilot study. Ultrasound Obstet Gynecol (2014) 1.45

Chlorpromazine: concentrations in plasma, excretion in urine and duration of effect. Proc R Soc Med (1971) 1.43

A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. The Dichloroacetate-Lactic Acidosis Study Group. N Engl J Med (1992) 1.42

Factors affecting chlorpromazine plasma levels in psychiatric patients. Arch Gen Psychiatry (1970) 1.42

Thermosensitive antibiotic resistance plasmids in enterobacteria. J Gen Microbiol (1978) 1.40

Intestinal obstruction with hemp bedding. Vet Rec (1996) 1.39

Uptake of disodium cromoglycate in obstructive airways disease. Clin Allergy (1973) 1.38

Natural history and course of acquired lactic acidosis in adults. DCA-Lactic Acidosis Study Group. Am J Med (1994) 1.38

An initial investigation of spinal mechanisms underlying pain enhancement induced by fractalkine, a neuronally released chemokine. Eur J Neurosci (2005) 1.36

Physiologic and clinical effects of chlorpromazine and their relationship to plasma level. Clin Pharmacol Ther (1973) 1.36

Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitis. Transpl Infect Dis (2002) 1.34

A polycistronic mRNA specified by the coronavirus infectious bronchitis virus. Virology (1991) 1.32

Plasma protein binding of chlorpromazine. J Pharm Pharmacol (1970) 1.30

Plasma levels of chlorpromazine and some of its relatively non-polar metabolites in psychiatric patients. Life Sci (1968) 1.29

Studies of delayed-action medication. V. Plasma levels and urinary excretion of four different dosage forms of chlorpromazine. Clin Pharmacol Ther (1970) 1.28

The physiological disposition of chlorpromazine in the rat and dog. Proc Soc Exp Biol Med (1970) 1.28

Regional and physical mapping studies characterizing the Greig polysyndactyly 3;7 chromosome translocation, t(3;7)(p21.1;p13). Genomics (1989) 1.27

Expression of bacteriophage T7 RNA polymerase in avian and mammalian cells by a recombinant fowlpox virus. J Gen Virol (1996) 1.27

Molecular confirmation of bacillus Calmette-Guérin as the cause of pulmonary infection following urinary tract instillation. Clin Infect Dis (1993) 1.26

Regional localization of the autosomal dominant polycystic kidney disease locus. Genomics (1988) 1.26

Plasma concentrations in the monkey (Macaca mulatta) of six related benzodiazepines after intraperitoneal injection [proceedings]. Br J Pharmacol (1976) 1.24

Early neurogenesis of the Drosophila brain. J Comp Neurol (1996) 1.24

Two inhibitors of pro-inflammatory cytokine release, interleukin-10 and interleukin-4, have contrasting effects on release of soluble p75 tumor necrosis factor receptor by cultured monocytes. Eur J Immunol (1994) 1.21

Symptom expectation after minor head injury. A comparative study between Canada and Lithuania. Clin Neurol Neurosurg (2001) 1.21

The 131-amino-acid repeat region of the essential 39-kilodalton core protein of fowlpox virus FP9, equivalent to vaccinia virus A4L protein, is nonessential and highly immunogenic. J Virol (1998) 1.14

Investigation of the factor VIII intron 22 repeated region (int22h) and the associated inversion junctions. Hum Mol Genet (1995) 1.13

Treatment of lactic acidosis with dichloroacetate. N Engl J Med (1983) 1.11

The role of fractalkine in the recruitment of monocytes to the endothelium. Eur J Pharmacol (2000) 1.11

Maternal depression and medication exposure during pregnancy: comparison of maternal retrospective recall to prospective documentation. BJOG (2008) 1.10

Forensic DNA tests and hardy-weinberg equilibrium. Science (1991) 1.09

Highly polymorphic RFLP probes as diagnostic tools. Cold Spring Harb Symp Quant Biol (1986) 1.09

Identification and characterization of 23 RFLP loci by screening random cosmid genomic clones. Am J Hum Genet (1989) 1.07

Criterion for the completeness of large-scale physical maps of DNA. Cold Spring Harb Symp Quant Biol (1993) 1.05

Linkage studies with chromosome 17 DNA markers in 45 neurofibromatosis 1 families. Genomics (1987) 1.05

Effort testing in patients with fibromyalgia and disability incentives. J Rheumatol (2001) 1.05

Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function. J Virol (2000) 1.04

Reinforcement of vocal correlates of auditory hallucinations by auditory feedback: a case study. Br J Psychiatry (1981) 1.03

A 12 megabase restriction map at the cystic fibrosis locus. Nucleic Acids Res (1989) 1.01

Production of cytokines, vascular endothelial growth factor, matrix metalloproteinases, and tissue inhibitor of metalloproteinases 1 by tenosynovium demonstrates its potential for tendon destruction in rheumatoid arthritis. Arthritis Rheum (2001) 1.01

Plasma-trifluoperazine concentrations during high dose therapy. Lancet (1981) 1.01

Preparation and stability of indomethacin solutions. Can J Physiol Pharmacol (1982) 1.00

Plasma concentrations and metabolic effects of intravenous sodium dichloroacetate. Clin Pharmacol Ther (1985) 1.00

Plasma disappearance and cerebral effects of chlorpromazine in cirrhosis. Clin Sci (1972) 0.99

Hemiparasitic plant impacts animal and plant communities across four trophic levels. Ecology (2015) 0.99

Destruction of chlorpromazine during absorption in the rat in vivo and in vitro. Br J Pharmacol (1971) 0.99

Obstetric skills drills: evaluation of teaching methods. Nurse Educ Today (2007) 0.99

S100A8 triggers oxidation-sensitive repulsion of neutrophils. J Dent Res (2006) 0.98

Complex regulatory region mediating tailless expression in early embryonic patterning and brain development. Development (1997) 0.98

Reactive carbonyl formation by oxidative and non-oxidative pathways. Front Biosci (2001) 0.98

Vagus nerve stimulation for epilepsy: randomized comparison of three stimulation paradigms. Neurology (2005) 0.98

Learning for a multicultural society. Br J Gen Pract (1996) 0.97

Chromosomal localization of ZFX--a human gene that escapes X inactivation--and its murine homologs. Genomics (1990) 0.97

Genetic linkage map of 46 DNA markers on human chromosome 16. Proc Natl Acad Sci U S A (1990) 0.97

Identifying the impact of diabetes research. Diabet Med (2006) 0.97

Sequence of human glucose-6-phosphate dehydrogenase cloned in plasmids and a yeast artificial chromosome. Genomics (1991) 0.97

Origin of mutation in sporadic cases of haemophilia-B. Eur J Haematol (1992) 0.96

Control of fat cell phosphohydrolase by lipolytic agents. Can J Biochem (1981) 0.96

Primary oral infaction of infants with Streptococcus mutans. Arch Oral Biol (1980) 0.95

Soluble rat adipocyte phosphatidate phosphatase activity: characterization and effects of fasting and various lipids. Biochim Biophys Acta (1977) 0.95

World Association for the Advancement of Veterinary Parasitology (W.A.A.V.P.) guidelines for evaluating the efficacy of acaricides against ticks (Ixodidae) on ruminants. Vet Parasitol (2005) 0.95

Chlorpromazine plasma levels and effects. Arch Gen Psychiatry (1970) 0.93

Nitroglycerin levels after administration via transdermal therapeutic system or nitroglycerin ointment. Lancet (1984) 0.92

Amikacin sulfate in mares: pharmacokinetics and body fluid and endometrial concentrations after repeated intramuscular administration. Am J Vet Res (1984) 0.92